Related Experiment Video
Updated: May 29, 2026
07:35
Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
Clozapine resistance: augmentation strategies
Stefano Porcelli1, Beatrice Balzarro, Alessandro Serretti
1Institute of Psychiatry, University of Bologna, Viale Carlo Pepoli 5, 40123 Bologna, Italy.
Summary
Adjunctive treatments for clozapine-resistant schizophrenia show limited evidence. Amisulpride, aripiprazole, mirtazapine, and E-EPA appear promising, but more research is needed for definitive conclusions on efficacy and safety.
Area of Science:
- Psychiatry
- Pharmacology
- Evidence-based Medicine
Background:
- Clozapine (CLZ) is ineffective for over 50% of schizophrenia patients.
- Treatment-resistant schizophrenia (TRS) necessitates alternative therapeutic strategies.
- Limited data exists on the safety and efficacy of adjunctive agents for TRS.
Purpose of the Study:
- To critically review literature on adjunctive agents for CLZ-resistant schizophrenia.
- To evaluate the efficacy and safety of various augmentation strategies.
- To perform meta-analyses for specific agents like lamotrigine and risperidone.
Main Methods:
- Conducted a 20-year Medline literature search.
- Identified 62 studies involving 1556 patients.
- Utilized Cochrane Collaboration Review Manager Software for meta-analysis.
Main Results:
- Evidence supports CLZ augmentation with amisulpride, aripiprazole, mirtazapine, and ethyl eicosapentaenoic acid (E-EPA).
- Electroconvulsive therapy (ECT) augmentation shows promise but requires further validation.
- Meta-analyses did not support risperidone or lamotrigine as effective CLZ adjuncts.
Conclusions:
- Overall evidence for adjunctive strategies in CLZ-resistant schizophrenia is scarce.
- Limitations include small sample sizes, variable definitions of resistance, and methodological heterogeneity.
- Definitive conclusions on efficacy and safety cannot be drawn due to study limitations.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...